BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 21, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

CellSearch continues to have favorable results 10 years later

Aug. 13, 2013
By Omar Ford

Researchers develop ultrasound patch to heal chronic wounds

Aug. 12, 2013
By Omar Ford
While some people might be able to heal from wounds in a fairly reasonable amount of time, there is a segment of the population that doesn't have this ability and often suffer from chronic wounds. Some of the most common chronic wounds are venous ulcers and these wounds affect about 500,000 U.S. patients annually, a number that's expected to increase as obesity rates climb. It's estimated that the treatment for venous ulcers costs the U.S. healthcare system over $1 billion dollars per year.
Read More

Ultrasound patch could aid in patient healing

Aug. 9, 2013
By Omar Ford
Marvel Comics' popular character Wolverine is known for his ability to heal from nearly any wound. Researchers at Drexel University in Philadelphia have developed an ultrasound technology aimed at giving patients who suffer from chronic wounds, an extra boost in recovering from the injuries. And while it's not anywhere near the level of Wolverine's powers (he is a fictional character after all), initial studies show promising results for the device. In the study, researchers treated patients suffering from venous ulcers, which account for 80% of all chronic wounds found on lower extremities and affect approximately 500,000 U.S. patients annually, a...
Read More

Tyrx launches bioresorbable antibacterial mesh device

Aug. 9, 2013
By Omar Ford

Medtronic unveils SCS tech. that can tolerate MRI scans

Aug. 7, 2013
By Omar Ford
Up until now, spinal cord stimulation patients referred for a body MRI were denied a scan due to concerns about the system being affected by the large magnetic fields and radio frequency energy involved in the imaging technique.
Read More

Hansen seeks AF treatment indication of Sensei X system

Aug. 6, 2013
By Omar Ford

Mitek Sports launches new Healix Knotless Anchor

Aug. 5, 2013
By Omar Ford

Integra receives clearance from FDA for reverse shoulder system

Aug. 2, 2013
By Omar Ford

Stereotaxis gains FDA clearance for Vdrive Robotic Navigation

July 31, 2013
By Omar Ford

Midwest firms raise $351 million; device funding up over pharma

July 30, 2013
By Omar Ford
Medical devices have outpaced pharmaceutical companies in terms of raising investment dollars from venture capitalist, according to the BioEnterprise (Cleveland) Midwest Venture Investment Report.
Read More
Previous 1 2 … 104 105 106 107 108 109 110 111 112 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Wireframe of feet and scale

    GLP-1s need technologies for long-term use

    BioWorld
    For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
  • UTRN gene involved in arthrogryposis, study finds

    BioWorld Science
    Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
  • Blue-gray dollar sign

    HMNC raises $50M series B to prep depression drugs for phase III

    BioWorld
    HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing